Show an ad over header. AMP

I am the FIRST!!!

U.S. market makes up more than 40% of COVID-19 vaccine sales

Data: Company filings; Chart: Sara Wise/Axios

The four main drug companies making COVID-19 vaccines have sold a combined $18.6 billion worth of the shots in the first half of 2021, and sales are expected to reach a combined $60 billion by the end of the year.

The big picture: Even though the U.S. represents less than 5% of the global population, the U.S. market makes up 41% of the vaccine sales.


Between the lines: Vaccine makers have sent more vaccines and charged higher prices to wealthy countries, including the U.S. The higher prices are part of the reason Pfizer and Moderna have advocated for booster shots even though their vaccines remain very effective after six months and against the Delta variant.

  • The World Health Organization has called for a moratorium on boosters so more unvaccinated people in low-income countries can get their first shots.

By the numbers: Pfizer and Moderna have collected more than 90% of global COVID-19 vaccine revenues.

  • Pfizer alone accounts for 60% of worldwide sales. Moderna's two-dose vaccine, which was 100% funded by the federal government, has more than half of its sales in the U.S.
  • Johnson & Johnson's one-shot vaccine hasn't sold nearly as much due to safety concerns, but the company still expects $2.5 billion of global sales this year based on its advanced purchasing agreements.
  • The FDA still hasn't authorized AstraZeneca's shot for use in the U.S. The company hopes it will before the end of the year. AstraZeneca has been selling its shot at a not-for-profit price.

regular 4 post ff

infinite scroll 4 pff

Sanofi, GSK COVID vaccine shows strong immune response in phase 2 trials

Sanofi and GSK announcedthis morning their COVID-19 vaccine candidate demonstrated a strong immune response in adults in a phase 2 clinical trial.

Why it matters: Sanofi and GSK say their recombinant protein-based vaccine candidate could ultimately serve as a universal COVID-19 vaccine booster, able to boost immunity regardless of the vaccination first received.

Keep reading...Show less

"Starfield” is Microsoft’s blockbuster Xbox game for 2022

“Starfield,” the next big game from the makers of “Fallout” and “The Elder Scrolls” will be released on Nov. 11, 2022 for Xbox consoles and PC — and not for PlayStation, according to a new trailer.

Why it matters: “Starfield” is about as big as it gets in terms of upcoming blockbuster games and will likely be ace for Microsoft commercially.

Keep reading...Show less

Mark Warner emerges as moderates' dealmaker-in-chief

As Senate Majority Leader Chuck Schumer (D-N.Y.) and White House Chief of Staff Ron Klain navigate the legislative minefield of the next few months, they'll often turn to a moderate Democrat who gets far less ink than Sens. Joe Manchin (D-W.Va.) or Kyrsten Sinema (D-Ariz.).

The big picture: Sen. Mark Warner (D-Va.) has become a pivotal player in the multi-trillion-dollar negotiations that will shape the Democrats' electoral prospects, Joe Biden's presidency and the future of the country.

Keep reading...Show less

Latin America and the Caribbean wait for COVID-19 vaccines

Data: Our World In Data; Map: Axios Visuals

Latin America and the Caribbeanhave the highest weekly death rate per capita of any region in the world, and it could climb, with vaccinations difficult to come by and hospitals still short on staff and equipment like ventilators and oxygen tanks.

Why it matters: Fewer than 10% of the people of Latin America and the Caribbean have been fully vaccinated against COVID-19 since immunization campaigns started in December, mostly due to the low availability of doses.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;